#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Though vision therapy is not a new treatment, many questions remain about what benefits it offers, and when and how it should be used. There has been a good deal of disagreement among professionals about its validity, and solid research findings are hard to come by.
One exception is a recent study funded by the National Eye Institute (NEI) and published in the journal Archives of Ophthalmology. Working at nine sites around the country, researchers held randomized, double-blind clinical trials using different types of vision therapy as the primary treatment for convergence insufficiency (CI) in children.
Over a period of 12 weeks, the researchers followed 221 children, ages 9 to 17, divided into four study groups:
At the end of the study, researchers found that:
This is one reason why we study vision therapy at Boston Children's Hospital.
Boston Children’s doctors and scientists have made many breakthrough discoveries about diseases like polio and leukemia; our ongoing innovative research continues to push the boundaries of the way pediatric medicine is practiced.
It’s possible that your child will be eligible to participate in one of Boston Children’s current clinical trials. These studies are useful for a multitude of reasons: Some trials are designed to evaluate the effectiveness of a particular drug, treatment or therapy on a specific disease; others help doctors to better understand how and why certain conditions occur. At any given time, Children’s has hundreds of clinical trials under way.
In 2009, the National Institutes of Health selected Children’s ophthalmology researcher Gabriel Kreiman, PhD, MSc, to receive its Director’s New Innovator Award. Learn more about Kreiman’s work.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”